Formation of formaldehyde from adrenaline in vivo: A potential risk factor for stress-related angiopathy

Neurochemical Research

Volumn 22, Issue 5, 1997, Pages 615-620

  Yu, Peter H ^a   Lai, Chien Tsai ^a   Zuo, Dong Mei ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

adrenaline; formaldehyde; Methylamine; monoamine oxidase (MAO); semicarbazide sensitive amine oxidase (SSAO); stress

Indexed keywords

ADRENALIN; FORMALDEHYDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY TEST; ENZYME ACTIVITY; ENZYME ANALYSIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; STRESS; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ANIMALIA; GYMNOMYZA SAMOENSIS;

EID: 0030998074     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022478221421     Document Type: Article

References (31)

1. Frankenhaeuser, M. 1971. Behavior and circulating catecholamines. Brain Res. 31:241-262.
2. von Euler, U. S. 1976. Adrenal medullary secretion and its neural control, pp 283-333 in Martini L., and Ganong W. F., (eds) Neuroendocrinology Vol. 2, New York: Academic Press.
3. Yu, P. H. 1986. Monoamine Oxidase. in Boulton, A. A., Baker, G. B., and Yu, P. H., eds. Neuromethods Volume V: Neurotransmitter Enzymes. New Jersey: Humana Press, Clifton, pp 235-272.
4. Yu, P. H. 1990. Deamination of aliphatic amines of different chain lengths by rat aorta semicarbazide-sensitive amine oxidase. J. Pharm. Pharmacol. 42:882-884.
5. Precious, E., Gunn, C. E., and Lyles, G. A. 1988. Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rat aorta. Biochem. Pharmacol. 37:707-713.
6. Lyles, G. A., Holt, A., and Marshal, C. M. S. 1990. Further studies on the metabolism of methylamine by semicarbazide-sensitive amine oxidase activities in human plasma. J. Pharm. Pharmacol. 42:322-338.
7. Boor, P., Trent, M. B., Lyles, G. A., Tao, M., and Ansari, G. A. S. 1992. Methylamine metabolism to formaldehyde by vascular semicarbazide-sensitive amine oxidase. Toxicology 73:251-258.
8. Yu, P. H., Davis, D. A., and Boulton, A. A. 1992. Aliphatic propargylamines: potent selective irreversible monoamine oxidase B inhibitors. J. Med. Chem. 35:3705-3713.
9. Yu, P. H., and Zuo, D. M. 1993. Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells; Possible consequence for diabetes. Diabetes 42:594-603.
10. Matsumoto, Y., Uyama, O., Shimizu, S., Michishita, H., Mori, R., Owada, T., and Sugita, M. 1993. Do anger and aggression affect carotid atherosclerosis. Stroke 24:983-986.
11. Tagawa, R. R., and Hosaka, T. 1990. Study of the correlation between the type A behavior pattern in patients with coronary heart disease and the extent of coronary atherosclerosis. Tokai. J. Exp. Clin. Med. 1:45-50.
12. Gallacher, J. E., Yarnell, J. W., and Butland, B. K. 1988. Type A behavior and prevalent heart disease in the Caerphilly study: increase in risk or symptom reporting? J. Epidemiol. Commun. Health 63:226-231.
13. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63.
14. Lyles, G. A., and McDougall, S. A. 1989. The enhanced daily excretion of urinary methylamine in rats treated with semicarbazide or hydralazine may be related to the inhibition of semicarbazide-sensitive amine oxidase activities. J. Pharm. Pharmacol. 41:97-100.
15. Yu, P. H., and Zuo, D. M. 1996. Formaldehyde produced endogenously via deamination of methylamine; a potential risk factor for initiation of endothelial injury. Atherosclerosis 120:189-197.
16. Dar, M. S., Morselli, P. L., and Bowman, E. R. 1985. The enzymatic systems involved in the mammalian metabolism of methylamine. Gen. Pharmacol. 16:557-560.
17. Baba, S., Watanabe, Y., Gejyo, F., and Arakwa, M. 1984. High-performance liquid chromatographic determination of serum aliphatic amines in chronic renal failure. Clin. Chim. Acta. 136:49-56.
18. Bolt, H. M. 1987. Experimental toxicology of formaldehyde. J. Can. Res Clin. Oncol. 13:305-309.
19. Grafstrom, R. C., Curren, R. D., Yang, L. L., and Harris, C. C. 1985. Genotoxicity of formaldehyde in cultured human bronchial fibroblasts. Science 228:89-91.
20. Gibson, J. E. (ed.). 1983. Formaldehyde Toxicity. Hemisphere Publ., Washington, New Jersey.
21. Cooper, J. R., and Kini, M. M. 1962. Editorial biochemical aspects of methanol poisoning. Biochem. Pharmacol. 11:405-416.
22. Tsuboi, S., Kawase, M., Takaka, A., Hirmatus, M., Wada, Y., Kawakami, Y., Ikeka, M., and Ohmori, S. 1992. Purification and characterization of formaldehyde dehydrogenase from rat liver cytosol. J. Biochem. 111:465-471.
23. Malorny, G. N., Rietbrock, N., and Schneider, M. 1965. The oxidation of formaldehyde to formic acid in the blood. A contribution to the metabolism of formaldehyde. Schmiedebergs Arch. Exp. Path. Pharmak. 250:419-436.
24. Helander, A., and Tottmar, O. 1987. Metabolism of biogenic aldehydes in isolated human blood cells, platelets and in plasma. Biochem. Pharmacol. 36:1077-1082.
25. Zuo, D. M., and Yu, P. H. 1993. Semicarbazide-sensitive amine oxidase and monoamine oxidase in rat brain microvessels, meninges, retina and eye sciera. Brain Res. Bull. 33:307-311.
26. Halliwell, B., and Gutteridge, J. M. C. (eds). 1989. Free radicals in biology and medicine. New York, N.Y. Oxford University Press.
27. Sackett, D. L., and Winkelstein, W. 1967. The relationship between cigarette usage and aortic atherosclerosis. Am. J. Epidemiol. 86:264-270.
28. Wilens, S. L., and Plair, C. M. 1962. Cigarette smoking and atherosclerosis. Science 138:975-977.
29. Cryer, P. E., Haymond, M. W., Santiago, J. V., and Shad, S. D. 1967. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated haemodynamic and metabolic events. N. Engl. J. Med. 295:573-577.
30. US Dept Health and Human Services. 1982. Constituents of tobacco smoke. USPHS Publication No. 82-50179, 322.
31. McKennis, Jr. H., Turnbull, L. B., Schwartz, S. L., Tamake, E., and Bowman, E. R. 1962. Demethylation in the metabolism of (-)-nicotine. J. Biol. Chem. 237:541-546.